March 2013 FDA Recall Venlafaxine by Zydus Pharmaceuticals Usa Inc
D-202-2013 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on March 5, 2013 for the product Venlafaxine. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-202-2013

Reason for Recall
Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.
Initiated
03-05-2013
Reported
04-03-2013
Quantity
13,320 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals USA Inc
Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.

Batch or Lot Expiration Information

Lot# : MM8490, Exp 09/14